Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Entergy
ETR
|
+$79.1M |
| 2 |
DTE Energy
DTE
|
+$73.2M |
| 3 |
FedEx
FDX
|
+$48.6M |
| 4 |
Marathon Petroleum
MPC
|
+$47.5M |
| 5 |
CMS Energy
CMS
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$75.8M |
| 2 |
ExxonMobil
XOM
|
+$62M |
| 3 |
Linde
LIN
|
+$49.9M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$38.6M |
| 5 |
Expedia Group
EXPE
|
+$29.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.24% |
| 2 | Technology | 13.54% |
| 3 | Utilities | 9.55% |
| 4 | Financials | 8.68% |
| 5 | Healthcare | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Hawaiian Electric Industries
HE
$1.97B
| $226K | ﹤0.01% |
+5,534
| New | +$233K |
|
1627
TG Therapeutics
TGTX
$8.57B
| $225K | ﹤0.01% |
52,853
+4,223
| +9% | +$26.4K |
|
1628
Sportradar
SRAD
$3.88B
| $224K | ﹤0.01% |
+28,372
| New | +$310K |
|
1629
Offerpad Solutions
OPAD
$20.7M
| $223K | ﹤0.01% |
683
-389
| -36% | -$261K |
|
|
ELP
1630
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $222K | ﹤0.01% |
43,700
+30,586
| +233% | +$175K |
|
1631
iShares MSCI Taiwan ETF
EWT
$11.2B
| $222K | ﹤0.01% |
4,400
-1,900
| -30% | -$106K |
|
1632
First Financial Bancorp
FFBC
$3.46B
| $222K | ﹤0.01% |
+11,432
| New | +$238K |
|
1633
Janus International
JBI
$696M
| $222K | ﹤0.01% |
24,574
-139,781
| -85% | -$1.36M |
|
1634
DoorDash
DASH
$99.3B
| $221K | ﹤0.01% |
3,445
-10,864
| -76% | -$863K |
|
1635
Sociedad Química y Minera de Chile
SQM
$23.5B
| $221K | ﹤0.01% |
+2,640
| New | +$232K |
|
1636
SiteOne Landscape Supply
SITE
$4.16B
| $220K | ﹤0.01% |
1,854
-7,395
| -80% | -$992K |
|
1637
Dr. Reddy's Laboratories
RDY
$10.2B
| $216K | ﹤0.01% |
19,500
+850
| +5% | +$9.24K |
|
1638
Scansource
SCSC
$1.1B
| $216K | ﹤0.01% |
+6,950
| New | +$244K |
|
1639
Simmons First National
SFNC
$3.32B
| $214K | ﹤0.01% |
+10,066
| New | +$244K |
|
|
AAN
1640
DELISTED
The Aaron's Company Inc
AAN
| $213K | ﹤0.01% |
+14,658
| New | +$280K |
|
1641
iRhythm Holdings
IRTC
$4.13B
| $211K | ﹤0.01% |
+1,954
| New | +$259K |
|
1642
ACV Auctions
ACVA
$1.27B
| $210K | ﹤0.01% |
32,105
-245,341
| -88% | -$2.53M |
|
1643
SunCoke Energy
SXC
$816M
| $210K | ﹤0.01% |
+30,801
| New | +$248K |
|
1644
TriCo Bancshares
TCBK
$1.74B
| $209K | ﹤0.01% |
+4,586
| New | +$193K |
|
1645
Telephone and Data Systems
TDS
$3.81B
| $209K | ﹤0.01% |
+13,257
| New | +$237K |
|
1646
Standex International
SXI
$3.67B
| $208K | ﹤0.01% |
+2,454
| New | +$230K |
|
1647
Central Pacific Financial
CPF
$972M
| $207K | ﹤0.01% |
+9,628
| New | +$234K |
|
1648
Markel Group
MKL
$22.5B
| $207K | ﹤0.01% |
+160
| New | +$220K |
|
1649
Pitney Bowes
PBI
$2.27B
| $207K | ﹤0.01% |
+57,086
| New | +$260K |
|
1650
Autoliv
ALV
$9.02B
| $206K | ﹤0.01% |
+2,878
| New | +$215K |
|
Similar funds
Michael Gelband's Q2 2022 Portfolio in Review
As of Q2 2022, Michael Gelband held 2,786 positions worth $8.16B, up 3.1% from $7.91B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Michael Gelband deployed $1.5B of net new capital in Q2 2022, opening 644 new positions and adding to 646 existing holdings. Its largest new stake was Marathon Petroleum: 508,082 shares worth $41.8M.
By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Utilities.
On the sell side, the largest reduction was AT&T, an estimated $75.8M trimmed.
- Michael Gelband's largest Q2 2022 buy was Marathon Petroleum: 508,082 shares worth $41.8M.
- Michael Gelband added most to Entergy in Q2 2022, an estimated $79.1M increase.
- Michael Gelband's biggest Q2 2022 reduction was AT&T, cutting an estimated $75.8M.
- Michael Gelband fully exited Linde in Q2 2022, selling an estimated $49.9M.
- Michael Gelband's ten largest holdings make up 14% of its $8.16B portfolio in Q2 2022.
- Michael Gelband opened 644 new positions and closed 902 in Q2 2022.
- Michael Gelband's portfolio value rose 3.1% quarter-over-quarter to $8.16B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.